Tue.Jun 11, 2024

article thumbnail

Four Tops singer’s lawsuit says he visited ER for chest pain, ended up in straightjacket

STAT

When Alexander Morris, a member of the Motown group The Four Tops , visited a Detroit-area Ascension hospital with chest pain and trouble breathing, he said the staff assumed he was mentally ill after he told them he was a famous singer. Instead of treating Morris, a white security guard told him to “sit his Black ass down” and he was placed in a straightjacket, Morris claims in a new lawsuit.

Hospitals 364
article thumbnail

As Big Pharma places bigger bets on ADCs, here’s where the field is headed next

PharmaVoice

With more drugmakers getting into the antibody-drug conjugate game, emerging innovations signal a bright future for the technology.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Empathy should guide responses to reported vaccine injuries

STAT

As a co-leader of the team at the National Institutes of Health that developed technologies powering a number of Covid-19 vaccines, I often speak publicly about vaccine science, even though I no longer work for the government. After my talks, people often approach me, almost always thanking me for my work. There is no denying the millions of lives that Covid-19 vaccines saved. sometimes, though, they relate stories of vaccine injuries.

Vaccines 363
article thumbnail

2024 Commonwealth Pharmacists Day -Pharmacists developing resilient and sustainable health systems

Commonwealth Pharmacists Association

2024 Commonwealh Pharmacists Day -Pharmacists developing resilient and sustainable health systems About the Day Welcome to the official page for Commonwealth Pharmacists Day, celebrated every year on the 16th of June! This year, we have chosen the theme: “Pharmacists developing resilient and sustainable health systems”.

129
129
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Melinda French Gates, going solo, aims to influence reproductive rights in the U.S.

STAT

Last week, Melinda French Gates officially left the Bill & Melinda Gates Foundation with a $12.5 billion check from Bill Gates, per the terms of their separation. Her departure from the foundation she co-founded in 2000 had been announced in May , and on Friday she published a parting memo thanking all who worked with her during her tenure at the foundation.

359
359
article thumbnail

3rd to 7th June – This week in clinical trials

pharmaphorum

Get the latest updates on clinical trials from 3rd to 7th June involving companies like uniQure, Takeda, Otsuka, CatalYm, Agios, and Transgene. Stay informed on the latest developments in the field.

120
120

More Trending

article thumbnail

FDA wants to make the home a healthcare hub

pharmaphorum

The FDA is exploring ways to transform the home into a healthcare hub, bringing healthcare services closer to individuals. This article discusses the potential impact of this trend on the future of healthcare.

116
116
article thumbnail

Opinion: Blood tests for cancer detection aren’t yet ready for prime time

STAT

Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests , are a new method of detecting cancer early. While the concept is promising, these untested tests currently pose significant problems. MCEDs look for circulating DNA or cells from cancers. The goal is to detect cancer in its earliest stages in people without any signs or symptoms of the disease.

295
295
article thumbnail

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

pharmaphorum

An FDA advisory committee has delivered a strong endorsement to Eli Lilly’s Alzheimer’s disease therapy donanemab, voting unanimously that the safety and efficacy of the amyloid-busting drug support its approval. The independent advisors on the Peripheral and Central Nervous System Drugs Advisory Committee voted by 11 to zero that donanemab’s benefits outweigh its risks, and by the same margin that the data submitted by Lilly to support its efficacy was convincing.

115
115
article thumbnail

STAT+: Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app

STAT

For the second time in as many years, Google’s health tech spinout Verily is pivoting. The company announced Tuesday that it will phase out its chronic disease management app Onduo over the next year and a half as it transitions to a new, “evolved” product called Lightpath. Lightpath Metabolic, expected to be available in 2026, will not only include programs for people with type 1 and type 2 diabetes and hypertension — as the current iteration of Onduo does — b

Diabetes 291
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA clears Ipsen’s primary biliary cholangitis drug

pharmaphorum

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

114
114
article thumbnail

Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices

STAT

WASHINGTON — Senate health committee chair Bernie Sanders has called a vote to subpoena the chief of Novo Nordisk’s U.S. division over the company’s pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, his office announced Tuesday. The vote is scheduled for June 18. Sanders (I-Vt.) is seeking the appearance of Novo’s Doug Langa at a hearing next month.

Diabetes 288
article thumbnail

Purity, potency, and safety – affordably – in stem cell therapy

pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.

112
112
article thumbnail

STAT+: Tweezers? Wrenches? Researchers plot prosthetics’ future with tools, not hands

STAT

Nearly half of people with upper-limb prosthetics abandon them. They’re often uncomfortable, dysfunctional or just don’t feel like a part of someone’s body. But in a recent study in iScience , researchers made an unusual choice. They used virtual reality to try out bionic tools like tweezers or wrenches as hand prosthetics. The participants felt as or even more embodied with these tools compared with a “natural” hand.

279
279
article thumbnail

Ipsen drug for rare liver disease approved by FDA

BioPharma Dive

The medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could be cleared for the condition by August.

111
111
article thumbnail

STAT+: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, an EU contract for bird flu vaccine, and more

STAT

Greetings from London, with STAT reporter Andrew Joseph here filling in for Ed. We’re dealing with some decidedly June Gloom today, though we suppose that makes it easier to sit in front of a computer instead of longing to escape outside. Whatever you need to power through your day, and your week, we hope you find it. Now to the news tidbits.

Vaccines 237
article thumbnail

UK pharma industry delivers election ‘wish list’

pharmaphorum

The Association of the British Pharmaceutical Industry (ABPI) is calling on political parties contesting the general election to spell out their plans to nurture and drive growth in the life sciences sector and deliver for patients.

110
110
article thumbnail

FDA says it’s getting serious about illegal vapes. It’s still likely to get a tongue lashing.

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. BIOSECURE might hitch a ride with a key defense bill Here at STAT we’ve not reported much on the annual National Defense Authorization Act, so it was surprising to learn that more than 1,300 amendments have been submitted to that bill for a House Rules Committee h

237
237
article thumbnail

EU orders bird flu vaccine supplies from CSL Seqirus

pharmaphorum

CSL Seqirus will provide 665,000 doses of bird flu vaccine to the European Commission to protect at-risk workers and guard against a potential outbreak

Vaccines 114
article thumbnail

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. My colleague Adam Feuerstein and I spent the day yesterday listening to the FDA advisory committee meeting on Lilly’s Alzheimer’s candidate. Read on for the outcome of the meeting, and also, who’s behind yet another new obesity startup.

article thumbnail

GSK et al file appeal to Delaware Zantac order

pharmaphorum

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian Medinilla of Delaware Superior Court issued an order ruling that cases claiming Zantac (ranitidine) could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap.

102
102
article thumbnail

Akira Endo, ‘remarkable’ scientist who discovered statins, dies aged 90

The Guardian - Pharmaceutical Industry

Biochemist found cholesterol-lowering compound in 1973 and the heart drugs have prolonged millions of lives The scientist whose work led to the creation of statins, a chemical that prevents heart attacks and strokes, has died aged 90. Akira Endo found the first cholesterol-lowering compound in 1973 in a lab in Tokyo. The Japanese biochemist was said to have been inspired by Alexander Fleming’s discovery of penicillin in 1928, which lead him to study mould or fungi in order to develop medicines.

article thumbnail

AstraZeneca Tagrisso sNDA gains FDA priority review for lung cancer

Pharmaceutical Technology

AstraZeneca's sNDA for Tagrisso has obtained FDA priority review for unresectable, Stage III EGFRm non-small cell lung cancer.

111
111
article thumbnail

Akums unveils new formulations for Gastrointestinal patients in India

Express Pharma

Akums Drugs and Pharmaceuticals unveiled Rabeprazole + Levosulpiride SR Capsules, approved by the Drug Controller General of India (DCGI), aiming to provide enhanced relief for patients with gastrointestinal tract (GIT) disorders. GERD, short for gastroesophageal reflux disease, is a debilitating condition marked by the regurgitation of stomach contents into the esophagus, causing distressing symptoms and potential complications.

Dosage 92
article thumbnail

FDA’s platform designation aims to ease R&D pain points

PharmaVoice

A new program creates approval pathways for multiple drugs developed on the same platform.

article thumbnail

Glenmark gets USFDA nod for Esomeprazole Magnesium DR Capsules USP, 20 mg

Express Pharma

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent to Nexium, 24 HR Delayed-Release Capsules, 20 mg (OTC), of Haleon US Holdings Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), will be distributed in the US by Glenmark Therapeutics, USA.

89
article thumbnail

ADCs are in focus. Here’s where AstraZeneca, AbbVie hope to take the field next.

BioPharma Dive

Newer components and drug combinations could expand use of the targeted cancer medicines, according to company executives.

107
107
article thumbnail

Kotak Alt acquires API business of Matrix Pharma

Express Pharma

Kotak Alternate Asset Managers (Kotak Alt), announced an investment of Rupees 1445 crore for the acquisition of API business of Viatris by Matrix Pharma. The acquisition has been consummated by the Kotak Strategic Situations Fund II. Upon acquisition, Matrix will be the 2nd largest Indian API player with global leadership in antiretroviral (ARV) APIs.

88
article thumbnail

LucyTx announces additional $12.5m research funding for neurological diseases

Pharma Times

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

111
111
article thumbnail

Is Combogesic IV revolutionizing pain management in the US healthcare market?

Outsourcing Pharma

Hikma Pharmaceuticals PLC has made a significant announcement, marking the US launch of Combogesic IV, an intravenous, opioid-free pain relief medication providing a multimodal approach to managing pain in adults.

82
article thumbnail

ALZpath licenses Alzheimer’s diagnosis tech to Roche

pharmaphorum

Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.

105
105
article thumbnail

What can UK pharmacists learn from strikes in France?

The Pharmacist

Jay Badenhorst, director of pharmacy at the Pharmacists’ Defence Association (PDA), reflects on the HSC report in light of the recent French pharmacists’ strike action. France, in the news this week with the announcement of a snap election, saw a one-day walkout by pharmacists at the end of May to highlight concerns about some issues […] The post What can UK pharmacists learn from strikes in France?

79
article thumbnail

5 PioneerRx Features to Manage Pet Prescriptions

PioneerRx

Man's best friend has a health journey too. A loyal patient base helps sustain your pharmacy in the long term. Through prescriptions and seasonal vaccines.

article thumbnail

US researchers develop AI liquid biopsy test to help identify lung cancer earlier

Pharma Times

The leading cause of cancer globally accounts for an estimated 1.

111
111
article thumbnail

Tories pledge £250m each year for Pharmacy First 2027-2030

The Pharmacist

The Conservative Party has set out spending plans of £250m each year on Pharmacy First from 2027 to 2030, as it pledges to expand the service to include more conditions like acne and chest infections. This comes on top of £20m in 2025/26 and £49m in 2026/27, as revealed by the party’s manifesto costing document, […] The post Tories pledge £250m each year for Pharmacy First 2027-2030 appeared first on The Pharmacist.